Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Enzyme Immunoassay for Hepcidin Detection | DRG International, Inc.
Connect with this vendor - Learn about this product

Enzyme Immunoassay for Hepcidin Detection

Current diagnostic tests for iron do not provide adequate information for the diagnosis, monitoring, and treatment of current iron-related diseases. Hepcidin is a recently discovered hormone that controls the absorption and distribution of iron in the body. Iron is essential for all organisms and the body must maintain a balance or serious health issues can occur. Unbalanced iron levels can lead to many common medical conditions including anemia and hemochromatosis, and it can cause chronic kidney disease, inflammation or diabetes mellitus. Excessive iron absorption, associated with low levels of Hepcidin, can lead to severe morbidity and mortality. Conversely, iron anemia due to low levels of iron in the blood affects roughly 1 billion people worldwide. DRG is very proud and equally pleased to introduce the DRG Hepcidin 25 ELISA, which will help revolutionize future research, diagnosis, and treatment of anemias and iron overload diseases. DRG’s Hepcidin 25 bioactive ELISA is a breakthrough product that is at the forefront of a new wave of diagnostic tests that will lead to better diagnosis and treatment of iron metabolism disorders.